Article

Emotional and Psychological Implications of Early AD Diagnosis

University Lille Nord de France, F-59000 Lille, France
The Medical clinics of North America (Impact Factor: 2.61). 05/2013; 97(3):459-75. DOI: 10.1016/j.mcna.2012.12.015
Source: PubMed

ABSTRACT

This article reviews the current recommendations in early diagnosis and the desires of the patients and their relatives, put in perspective with the reality of the clinical practices. More specific situations covered are: (1) the issue of young diseased patients, taking into account the psychological implications of the early occurrence of the disease in life and of the longer delay for these patients between the first observable signs and the diagnosis and (2) the issue of genetic testing, taking into account the implications of this extremely early form of bad news on the individual's existence and on the family structure.

Download full-text

Full-text

Available from: Pascal Antoine, Sep 28, 2014
  • Source
    • "Delay in treatment due to diagnostic incertitude, particularly frequent in atypical/unclear dementias, has important clinical and psychological consequences for patients and their families [4] [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diagnosis of atypical/unclear dementia is often difficult and this delays treatment initiation. Several authors have shown that beyond standard dementia workup, 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) reduces the number of unclear diagnoses, leads to earlier treatment, and has a beneficial impact on families. However, it is not uncommon that the FDG-PET findings are equivocal in this setting. For those cases, a repeat FDG-PET may clarify the diagnosis and prevent treatment delay. We retrospectively assessed the clinical impact of a repeat FDG-PET in 59 patients with atypical/unclear dementia syndromes and inconclusive initial FDG-PET. Changes in primary diagnosis, diagnostic confidence, and management following the second FDG-PET were examined. Conducting a second FDG-PET reduced the number of unclear diagnoses from 80% to 34% , led to diagnostic change in 24% of cases, and treatment modification in 22% of patients. Overall, the clinical impact was higher when initial diagnostic confidence was low and the second FDG-PET repeated ≥12 months after the first one. In tertiary care memory clinic settings, when diagnostic incertitude persists despite extensive evaluation and an equivocal FDG-PET, repeating the FDG-PET 12 months later can greatly clarify the diagnosis and improve the care management.
    Full-text · Article · Oct 2015 · Journal of Alzheimer's disease: JAD
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the past 8 years, both the International Working Group (IWG) and the US National Institute on Aging-Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's disease (AD) that better define clinical phenotypes and integrate biomarkers into the diagnostic process, covering the full staging of the disease. This Position Paper considers the strengths and limitations of the IWG research diagnostic criteria and proposes advances to improve the diagnostic framework. On the basis of these refinements, the diagnosis of AD can be simplified, requiring the presence of an appropriate clinical AD phenotype (typical or atypical) and a pathophysiological biomarker consistent with the presence of Alzheimer's pathology. We propose that downstream topographical biomarkers of the disease, such as volumetric MRI and fluorodeoxyglucose PET, might better serve in the measurement and monitoring of the course of disease. This paper also elaborates on the specific diagnostic criteria for atypical forms of AD, for mixed AD, and for the preclinical states of AD.
    Full-text · Article · Jun 2014 · The Lancet Neurology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives To explore the experiences and adjustment modes of couples during the period between the initial signs of the Alzheimer's disease (AD) and the years following diagnosis, particularly in the case of early-onset AD.DesignA dyadic interpretative phenomenological analysis was conducted with married couples in which one member of each couple received a diagnosis of probable early-onset AD (before 65 years of age).ParticipantsSixteen young couples, followed by the National Reference Centre for Young Persons with AD, agreed to participate. For seven of the couples, the caregiver was a woman. The mean age was 57.4 (SD = 4.2) for the caregivers and 57.3 (SD = 4.1) for the persons with AD.Methods The semi-structured interviews were conducted in the couples' homes. Each interview was conducted with both spouses to capture their interactions in the context of individual and shared experiences.ResultsTwo higher-order themes emerged from the analyses: the ‘need to know’ and, after the diagnosis, the ‘need not to know more’. Indeed, the first signs mark the beginning of a period of doubt and a search for understanding. This pursuit of knowledge progresses to the recognition of more intense and severe signs that encourage couples to seek medical attention. Both reassuring and destabilising, the diagnosis is a breaking point that modifies how the changes and painful effects associated with disease are experienced. Couples employ strategies to minimise their suffering and consequently their knowledge about the disease.Conclusions These results show that the couples oscillate between the need to know and the fear of knowing. To protect themselves, they use strategies to reduce their suffering and to distance the disease. The use of these avoidance strategies indicates that certain times in the course of disease management are less appropriate for couples to accept the assistance offered by formal caregivers.
    No preview · Article · Oct 2015 · Scandinavian Journal of Caring Sciences
Show more

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.